A higher risk of adult psychotic experiences is associated with childhood cat ownership.

Published Date: 24 Apr 2023

Canada: The Journal of Psychiatric Research recently reported that childhood cat ownership, particularly with rodent-hunting cats,.

Read Full News

Latest News

Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies

Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies

Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms

Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms

Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms

Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms

Q4 2025 Recap: Psychiatry News and Updates

Q4 2025 Recap: Psychiatry News and Updates

Switching Therapists for Psychotherapy Offers No Advantage in MDD

Switching Therapists for Psychotherapy Offers No Advantage in MDD

Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD

Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD

Todays Updates

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Todays Updates

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Latest News

Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies

Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms

Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms

Q4 2025 Recap: Psychiatry News and Updates

Switching Therapists for Psychotherapy Offers No Advantage in MDD

Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD

News All Time

FDA Releases CRL Detailing Safety Concerns for MDMA-Assisted Therapy in PTSD Chelsie Derman

MDMA’s CRL, now available to the public, cites gaps in safety data, selection bias, and limited durability.

Prenatal Opioid Pain Medications Likely Not Linked to Autism or ADHD Risk Chelsie Derman

A study suggests associations between opioids during pregnancy and neurodevelopmental disorders are mainly due to confounding factors, not causal effects.

Atopic Eczema Linked to Suicidal Ideation in Global Study of 30,000 Adults Chelsie Derman

EADV 2025 findings show patients with atopic eczema face greater risks of depression, anxiety, sleep disorders, and stigmatization.

FDA Initiates Acetaminophen Label Change, Leucovorin Approval for Cerebral Folate Deficiency Abigail Brooks, MA

The Agency initiated an acetaminophen label change to reflect evidence of potential harms in pregnant women and an approval of leucovorin for CFD.

Daily Ammoxetine at 40, 60 mg Outperforms Placebo for MDD in Phase 2 Trial Chelsie Derman

A phase 2 trial demonstrated the effectiveness, safety, and tolerability of ammoxetine (40 and 60 mg) in patients with major depressive disorder.

APhA, Coalition of Autism Scientists Cite Insufficient Data to Support Acetaminophen, Autism Link Abigail Brooks, MA

Both organizations defend the use of Tylenol during pregnancy, citing “rigorous” and “reputable” research suggesting it does not cause autism in children.

5 Psychiatry Headlines You Missed in September 2025 Chelsie Derman

This month in review focuses on innovative therapies in psychiatry, including MM120 for anxiety and ammoxetine for depression, as well as providing safety insights.

Q3 2025 Recap: Psychiatry News and Updates Chelsie Derman

Explore the latest advancements in psychiatry, including FDA updates, emerging therapies, and promising clinical trial results for mental health treatments.

I Tried to End My Life 3 Times: Today, I Help Others Fight for Theirs Diana Guzman, LMHC

Therapist Diana Guzman, LMHC, writes about attempting suicide despite counseling patients battling with suicidal ideation.

FDA Approves Risperidone Extended-Release Injectable for Bipolar I Disorder Chelsie Derman

FDA approves UZEDY, a long-acting risperidone injection, for adults with bipolar I disorder.

Digital Therapeutic Reduces Negative Symptoms of Schizophrenia in Phase 3 Trial Chelsie Derman

A new digital therapeutic, CT-155, shows promise in reducing negative symptoms of schizophrenia.

Soft Drinks Linked to Depression Through Gut Microbiota Alterations Chelsie Derman

New research links soft drink consumption to depression, revealing gut microbiota changes as a potential mediator, particularly in women.

Early Heart Rate Slowing Predicts Magnetic Brain Stimulation Response in MDD Chelsie Derman

Study finds heart rate deceleration within 45 seconds of iTBS may serve as a biomarker for improved depression outcomes, regardless of stimulation site.

Esmethadone Shows Promise as Adjunctive Treatment for Antidepressant Tolerance Chelsie Derman

Post-hoc analysis of a phase 3 trial reveals significant improvements in patients with MDD experiencing tachyphylaxis.

Magnetic Seizure Therapy Rivals ECT, Protects Cognition in Adolescent MDD Chelsie Derman

A study found magnetic seizure therapy matched ECT’s antidepressant efficacy while offering better cognitive preservation and fewer adverse events.

Antidepressants Differ Significantly in Cardiometabolic Side Effects Chelsie Derman

A large analysis reveals clinically relevant differences in weight, blood pressure, and heart rate across 30 antidepressants.

Recommended News For You

In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

Study sheds light on challenges for women of color after breast cancer surgery

Research indicates that combining AI models enhances the ability to predict breast cancer risk.

Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

When a Groundbreaking Cancer Therapy Causes Cancer.

Recommended Articles For You

Mechanistic Insights into Abraxane, Verzenio, and the Management of Chemotherapy-Induced Tachycardia 

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment 

The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Low-Dose Radiation Provides Almost Perfect Control Over Slow-Growing Lymphoma.

2.

Chronic pain and poor sleep are troublesome bed partners.

3.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

4.

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

5.

combating racial discrimination in next-generation breast cancer screening.

1.

Exploring the Use of Bevacizumab in Treating Different Types of Cancers 

2.

A New Hope: How Procarbazine is Revolutionizing Cancer Treatment

3.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

4.

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense

5.

Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part VI

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

3.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

5.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot